340 related articles for article (PubMed ID: 10803687)
1. Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection.
Park JW; Kim DJ; Kim J; Park CG; Hwang ES; Cha CY
J Korean Med Sci; 2000 Apr; 15(2):133-8. PubMed ID: 10803687
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
Navarro D; Lennette E; Tugizov S; Pereira L
J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
Muñoz I; Gutiérrez A; Gimeno C; Farga A; Alberola J; Solano C; Prósper F; García-Conde J; Navarro D
J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.
Marshall GS; Rabalais GP; Stout GG; Waldeyer SL
J Infect Dis; 1992 Feb; 165(2):381-4. PubMed ID: 1309850
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response.
Urban M; Klein M; Britt WJ; Hassfurther E; Mach M
J Gen Virol; 1996 Jul; 77 ( Pt 7)():1537-47. PubMed ID: 8757997
[TBL] [Abstract][Full Text] [Related]
7. Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection.
Alberola J; Tamarit A; Igual R; Navarro D
J Clin Virol; 2000 Apr; 16(2):113-22. PubMed ID: 10720815
[TBL] [Abstract][Full Text] [Related]
8. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy.
Eggers M; Radsak K; Enders G; Reschke M
J Med Virol; 2001 Feb; 63(2):135-42. PubMed ID: 11170050
[TBL] [Abstract][Full Text] [Related]
9. Antibody response to human cytomegalovirus (HCMV) glycoprotein B (gB) in AIDS patients with HCMV end-organ disease.
Alberola J; Domínguez V; Cardeñoso L; López-Aldeguer J; Blanes M; Estellés F; Ricart C; Pastor A; Igual R; Navarro D
J Med Virol; 1998 Aug; 55(4):272-80. PubMed ID: 9661835
[TBL] [Abstract][Full Text] [Related]
10. Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response.
Cui X; Cao Z; Wang S; Lee RB; Wang X; Murata H; Adler SP; McVoy MA; Snapper CM
Vaccine; 2018 Sep; 36(37):5580-5590. PubMed ID: 30082162
[TBL] [Abstract][Full Text] [Related]
11. Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus.
Wiegers AK; Sticht H; Winkler TH; Britt WJ; Mach M
J Virol; 2015 Jan; 89(1):361-72. PubMed ID: 25320309
[TBL] [Abstract][Full Text] [Related]
12. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
[TBL] [Abstract][Full Text] [Related]
13. Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity.
Kirchmeier M; Fluckiger AC; Soare C; Bozic J; Ontsouka B; Ahmed T; Diress A; Pereira L; Schödel F; Plotkin S; Dalba C; Klatzmann D; Anderson DE
Clin Vaccine Immunol; 2014 Feb; 21(2):174-80. PubMed ID: 24334684
[TBL] [Abstract][Full Text] [Related]
14. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.
Tugizov S; Navarro D; Paz P; Wang Y; Qadri I; Pereira L
Virology; 1994 Jun; 201(2):263-76. PubMed ID: 8184537
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response.
Shimamura M; Mach M; Britt WJ
J Virol; 2006 May; 80(9):4591-600. PubMed ID: 16611919
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to the major linear neutralizing domains of cytomegalovirus glycoprotein B among natural seropositives and CMV subunit vaccine recipients.
Marshall GS; Li M; Stout GG; Louthan MV; Duliège AM; Burke RL; Hunt LA
Viral Immunol; 2000; 13(3):329-41. PubMed ID: 11016597
[TBL] [Abstract][Full Text] [Related]
17. Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response.
Britt WJ; Vugler L; Butfiloski EJ; Stephens EB
J Virol; 1990 Mar; 64(3):1079-85. PubMed ID: 2154594
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells.
Navarro D; Paz P; Tugizov S; Topp K; La Vail J; Pereira L
Virology; 1993 Nov; 197(1):143-58. PubMed ID: 7692667
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
[TBL] [Abstract][Full Text] [Related]
20. Location, location, timing: analysis of cytomegalovirus epitopes for neutralizing antibodies.
Schrader JW; McLean GR
Immunol Lett; 2007 Sep; 112(1):58-60. PubMed ID: 17714794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]